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Abstract
Glycerol uptake and glycerol kinase activity were studied in primary cultures of rat hepatocytes in the presence of either
1 nM insulin, 1 nM glucagon, or 100 nM dexamethasone, alone or in combination in the culture medium. Glycerol uptake
 .  .exhibited saturation kinetic with K values mM and V nmolrmin=mg protein ranging from 250–402, andm max
7.9–10.1, respectively. The corresponding K and V values for glycerol kinase activity were 36–46 and 8.7–12,7.m max
Using the metabolic uncoupler 2,4-dinitrophenol, glycerol uptake and the cellular content of glycerol phosphorylated
metabolites were reduced 33% and 43%, respectively, whereas no decrease in the cellular content of glycerol was seen. The
glycerol analogues monoacetin, monobutyrin and dihydroxypropyl dichloroacetate were able in a concentration-dependent
manner to inhibit glycerol uptake into hepatocytes with the two latter having IC values of approximately 1 mM.50
Moreover, it was demonstrated that the three glycerol analogues were substrates for glycerol kinase, which indicates a
competitive mode of inhibition. The kinetic parameters for these substrates were calculated by using glycerol kinase from
Candida Mycoderma. Monobutyrin was found to be 4 times lees efficient as substrate compared to the other substrates.
Overall, these results indicate that independently of the culture conditions, glycerol uptake is the rate-limiting step in
glycerol metabolism, and that the investigated glycerol analogues are metabolized via the same route as glycerol. q 1998
Elsevier Science B.V.
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1. Introduction
Plasma glycerol is made available from lipolysis of
triglycerides in adipose tissues and from hydrolysis
of dietary fat. In glycerol metabolism the liver plays a
pivotal role, since it is responsible for 70–90% of the
) Corresponding author. Novo Nordisk, Diabetes Biochemistry
and Metabolism, Building 6B, Novo Alle, DK-2880 Bagsværd,
D enm ark . Fax: q 45-44-44-09-93; E -m ail:
nwe@novo.dk
w xtotal body capacity for glycerol utilization 1,2 . After
uptake, glycerol is irreversibly converted by glycerol
 .  .kinase GK to glycerol-3-phosphate G-3-P . This
compound acts as a carrier for reducing equivalents
from the cytosol to the mitochondria as part of the
w xglycerol phosphate shuttle 1,3 , constitute the back-
w xbone in triglycerides 2 , and provides carbon skele-
w xton for gluconeogenesis 4–6 . Glycerol is a unique
gluconeogenic substrate as it provides new carbons
w xfor gluconeogenesis 6,7 , in contrast to lactate and
alanine whose carbons originate directly from plasma
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w xglucose 8,9 . In non-insulin-dependent diabetes mel-
 .litus NIDDM , it has been shown that the appear-
ance of glycerol in plasma is elevated due to in-
creased lipolysis. Moreover, the conversion of glyc-
erol to glucose accounts for approximately 80% of
the total glycerol turnover in diabetes as opposed to
w xonly 40–60% under normal conditions 4,5 . How-
ever, the increase in glycerol-derived gluconeogene-
sis appears not to be exclusively a result of acceler-
ated lipolysis, but also of altered intrahepatic han-
w xdling of glycerol 4,5 .
Glycerol uptake has previously been studied in
w x w xtumor cells 10 , freshly isolated rat hepatocytes 11 ,
w xand in perfused liver 12 . However, remarkably little
is known about glycerol uptake into liver cells, how
uptake is regulated by hormones, and how its avail-
ability as a precursor for the synthesis of glucose
might be dependent upon uptake or the activity of
GK in the liver cells. To gain knowledge about this,
hepatocytes were cultured in the presence of different
concentrations of insulin, glucagon and glucocorti-
 .coids dexamethasone . Glycerol uptake in the pres-
ence or absence of the metabolic uncoupler 2,4-di-
 .nitrophenol DNP and GK activity were then mea-
sured to see whether glycerol uptake or GK activity
is rate-limiting for glycerol metabolism. In addition,
it was investigated whether the structural analogues
 .  .of glycerol, monoacetin MA , monobutyrin MB
and 2,3-dihydroxypropyl-dichloroacetate dichloro-
.MA , had any effects on glycerol uptake and GK
activity. Dichloro-MA and MA have previously been
w xshown to alter glycerol metabolism 11,13 .
2. Materials and methods
2.1. Materials
 .Adult male Wistar rats ca. 200 g were obtained
 .from Møllegard Breeding Center Denmark . Plastic˚
tissue culture dishes were purchased from Nunc
 .Denmark and foetal calf serum, culture medium 199
 .cat no. 3115-022 , penicillin, and streptomycin from
 .Life Technologies Denmark . Collagen was obtained
from Sigma Chemical Company, St. Louis, MO
 .USA , enzymes and co-enzymes from Boehringer,
 .Mannheim Germany and Whatman filters DE-81
 .were obtained from Whatman, Maidstone England .
Insulin and glucagon were from Novo Nordisk,
 .Bagsværd Denmark , dexamethasone from Merck,
 .Sharp and Dome, Haarlem The Netherlands and
w3 x  .H glycerol specific activity 72.5 Cirmmol was
purchased from Dupont-New England Nuclear,
 .Frankfurt Germany . Monoacetin was purchased
 .from Avocado, Lancashire UK and monobutyrin
 .from Acros, Pittsburgh USA . 2,3-Dihydroxypropyl
w xdichloroacetate 13 was prepared via reaction of
isopropylidene glycerol with dichloroacetyl chloride
followed by hydrolysis 15% aq. formic acidracetone,
.reflux 1 h .
2.2. Hepatocyte cultures
Hepatocytes were prepared essentially as described
w xby Dich and Grunnet 14 . The isolated cells, of
which more than 85% excluded trypan blue, were
suspended in Medium 199 containing 5.5 mM glu-
cose, 4% foetal calf serum and supplemented with 1
nM insulin plus 100 nM dexamethasone condition
.A , 1 nM glucagon plus 100 nM dexamethasone
 .  .condition B , 1 nM insulin alone condition C , 100
 .nM dexamethasone alone condition D , 1 nM
 .glucagon alone condition E or without addition of
 .hormones condition F . The cell suspension was
plated onto collagen-coated 35 mm Petri dishes 2
.mlrdish; 0.55 million cellsrml or in 24 multiwell
 .dishes 1.5 mlrdish; 0.15 million cellsrml . After 3
h, and subsequently every day, the medium was
changed with the same medium except that the serum
was omitted. Cells were cultured for 2 days.
2.3. Glycerol uptake
Hepatocytes for studies of glycerol uptake were
cultured in 24 multiwell dishes. Transport studies
were performed essentially as described for amino
w xacids 15,16 by exchanging the culture medium with
phosphate-buffered saline PBS; 137 mM NaCl, 2.7
mM KCl, 7.3 mM Na HPO 1.5 mM KH PO , 0.92 4, 2 4
mM CaCl , 0.5 mM MgCl and 6 mM glucose, pH2 2
.7.35 containing different concentrations of radio-
 .labelled glycerol range 1–1000 mM . An incubation
period of 1 min was used after demonstrating that
uptake was linear for at least 2 min results not
.shown . Uptake was terminated by rapid washes with
1 ml ice cold PBS twice. No radioactivity was lost
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from the cells during washing. The effects of differ-
 .ent glycerol analogues range 100–2000 mM on
glycerol uptake were studied in the presence of 100
w3 xmM H glycerol. After termination of uptake, cellu-
lar levels of radioactivity and protein content were
determined. In all experiments, radioactivity present
 . w3 xin cultures briefly exposed 1–2 s to H glycerol at
08C was subtracted from the experimental values
obtained at 378C. In some experiments hepatocytes
cultured in 35 mm Petri dishes were exposed to 100
mM DNP in PBS 5–10 min prior to uptake. The
medium was then changed to the same medium added
w3 x0.5 mM H glycerol for 1 min. Uptake was termi-
nated as described above by rapid washes with PBS
followed by addition of 200 ml 70% ethanol. The
culture dishes were placed at 378C to evaporate the
 .ethanol 10–15 min . Then 250 ml water was added
to each dish and cells were scraped of and placed in
test tubes and centrifuged at 10 000 rpm for 2 min. 50
ml of the supernatant was spotted onto a 2.5 mm
diameter DE-81 Whatman filter. The filters were
washed 4 times with 1 ml water. Radioactivity adher-
ing to the filters was considered as glycerol phospho-
rylated metabolites e.g. glycerol-3-phosphate, dihy-
.droxyacetone-phosphate and radioactivity passing
through the filters was considered as glycerol. On the
basis of the specific activity of glycerol in the incuba-
tion medium at the beginning of the experiment, the
cellular content of glycerol and glycerol phosphory-
lated metabolites as well as the glycerol uptake were
calculated.
The diffusion-related parts of the glycerol uptake
w xwere determined as previously described 17 using
 w x.  w x. w xthe equation: ˝s V = S r K q S qk= S ,max m
where ˝ indicates the velocity nmolrmin=mg pro-
.  .tein , K the Michaelis–Menten constant mM , km
the rate constant of the non-saturable influx compo-
 . w xnent mlrmin=mg protein , and S the substrate
 .concentration mM .
2.4. Glycerol kinase acti˝ity
After removal of the culture medium and rinsing
with ice-cold PBS individual cultures were scraped of
the 35 mm Petri dishes in a solution containing 1%
KCl and 1 mM EDTA. Subsequently, the cells were
homogenized and centrifuged for 2 min at 10,000
rpm and 50–100 ml aliquots the of supernatant were
assayed for glycerol kinase activity at 378C in a total
assay volume of 350 ml using two different assay
methods. Method I was a spectrophotometric assay
w xrunning at pH 9.1 18 employing glycerol-3-phos-
phate dehydrogenase and NADq to convert glycerol
3-phosphate to dihydroxyacetone-phosphate and
NADH after glycerol had been converted to glycerol-
 .Fig. 1. Velocity of glycerol uptake nmolrmin=mg protein in
 .  .hepatocytes cultured in the presence of A 1 nM insulin Ins
 .  .plus 100 nM dexamethasone Dex , B 1 nM glucagon plus 100
 .nM Dex, or C 1 nM Ins alone. The experimentally obtained
 .  .values for glycerol uptake B were resolved into saturable ’
 .and non-saturable components of glycerol uptake % . The diffu-
sion constant did not exceeded 0.004 mlrmin=mg protein.
Results are averages of four individual cell preparations with
SEM indicated by vertical bars.
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3-phosphate by GK. The structural analogues of glyc-
erol, MA, MB and dichloro-MA range 100–600
.mM , were studied in the presence of 100 mM glyc-
erol. Blanks were run in the absence of ATP. In some
cases a 2% solution of the commercially available
glycerol kinase from Candida Mycoderma was used
w xat 308C. Method II was a radioisotopic assay 11,19 .
The assay mixture contained 25 mM HEPES-buffer
 .pH 7.4 , 3 mM ATP, 2.5 mM MgCl and varying2
w3 x  .concentrations of H glycerol range 25–150 mM .
The reaction was initiated at 378C by addition of
aliquots of the supernatants. After 5 min blanks 1–5
.s the reaction was terminated by adding 150 ml of a
 .2 M glycerol solution 908C immediately followed
by placing the reaction vials into a 908C water bath
for 5 min. The vials were then centrifuged at 10,000
rpm for 2 min and 20 ml of the supernatant spotted
onto a 2.5 mm diameter DE-81 Whatman filter. The
filters were washed 4 times with 1 ml water. Radioac-
 .tivity adhering to the filters G-3-P was determined
by liquid scintillation. Method II was used to study
glycerol kinase activity vs. glycerol uptake, whereas
Method I was used to characterize the glycerol ana-
logues, since these could not be obtained in radio
labelled form.
2.5. Protein and statistics
Protein contents were measured using the Bio-Rad
DC Protein Assay using human serum albumin as the
standard.
 .V , K and statistics t-test, unpaired weremax m
 .calculated using GraphPad Prism GraphPad .
3. Results
3.1. Glycerol uptake
The kinetic characteristics of the uptake of glyc-
erol into rat hepatocytes cultured for two days in the
presence of either 1 nM insulin plus 100 nM dexa-
 .  .methasone Dex condition A , 1 nM glucagon plus
 .100 nM Dex condition B or 1 nM insulin alone
 .condition C are shown in Fig. 1. Glycerol uptake
could be resolved into a saturable process, from
 .which V and K were calculated Table 1 , and amax m
non-saturable diffusion process. The diffusion pro-
cess constituted less than 25% of the saturable uptake
at glycerol concentrations below 250 mM. No differ-
ences among K and V values were observed.m max
 .The Hill coefficients for glycerol uptake were A
 .  .1.1"0.1, B 1.1"0.1 and C 1.0"0.1 for the
different culture conditions.
In order to also compare the effect of Dex alone
 .  .condition D , glucagon alone condition E and no
 .addition of hormones condition F , uptake were also
measured for conditions A–F at a fixed glycerol
concentration of 0.5 mM. From Table 1 it can be
seen, that glucagon and Dex alone but not in combi-
nation caused a slight decrease in uptake.
Table 1
Kinetic parameters for glycerol uptake and glycerol kinase activity in cultured rat hepatocytes
Condition Glycerol uptake Glycerol kinase activity
K Vmax V K V V )m 0.5 mM glycerol m max max
 .  .  .  .mM nmolrmin=mg protein mM nmolrmin=mg protein
A: InsqDex 346"79 8.8"0.8 5.3"0.3 36"16 8.7"1.3 11.9"1.1
B: GlucqDex 250"91 7.9"1.1 5.8"0.7 46"22 9.3"1.7 9.5"1.6
C: Ins 402"96 10.1"1.1 5.8"1.3 36"15 10.0"1.4 10.9"1.2
D: Dex nd nd 3.4"0.2)) nd nd 9.8"0.8
E: Gluc nd nd 3.8"0.5)) nd nd 10.6"1.4
F: nd nd 4.9"0.3 nd nd 12.7"0.9
 .K and V for glycerol kinase activity were determined by Method II and V ) by Method I see Section 2 in cultured hepatocytes.m max max
 .Cells were cultured for two days as described in Section 2 in the presence of 1 nM insulin plus 100 nM dexamethasone condition A , 1
 .  .  .nM glucagon plus 100 nM dexamethasone condition B , 1 nM Insulin alone condition C , 100 nM dexamethasone alone condition D ,
 .  .1 nM glucagon alone E or without addition of hormones condition F .
V indicates uptake using 0.5 mM glycerol. Results are averages of three to eight individual cell preparations"SEM.0.5 mM glycerol
 .Statistically significant differences from conditions A )) P-0.01 are given.
ndsnot determined.
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To see whether a reduction in cellular ATP content
and thereby glycerol kinase activity could affect the
glycerol uptake and the cellular contents of glycerol
and its phosphorylated metabolites, assuming that
uptake does not demand energy, cells were incubated
in the presence or absence of 100 mM DNP. From
Fig. 2 it can be seen, that in the presence of DNP
glycerol uptake and the cellular content of phospho-
rylated metabolites were reduced by 33% and 44%,
respectively. No effect on the cellular content of
glycerol was observed.
The effects of the glycerol analogues MA, MB and
dichloro-MA on glycerol uptake in the presence of
100 mM glycerol were also investigated in order to
obtain information about the specificity of the trans-
port system. These uptake experiments were per-
formed using hepatocytes cultured as described for
 .condition A. All three analogues Fig. 3 were able to
inhibit glycerol uptake. MB and dichloro-MA were
the most potent with IC values of approximately 150
mM.
3.2. Glycerol kinase acti˝ity
Glycerol kinase is responsible for the conversion
of glycerol to G-3-P. In order to study if GK activity
 . Fig. 2. Glycerol uptake open bars , content of glycerol black
. bars and content of glycerol phosphorylated metabolites hatched
.bars in the absence or presence of 100 mM of the metabolic
 .uncoupler 2,4 dinitrophenol DNP . Glycerol uptake was deter-
w3 xmined in the presence of 500 mM H glycerol and the cellular
contents of glycerol and glycerol phosphorylated metabolites
were calculated from the specific activity of glycerol in the
incubation medium at the start of the incubation. Results are
averages of three individual experiments with SEM indicated by
vertical bars. Statistical significant differences from control
 .  .yDNP are given ) P -0.05; )) P -0.01 .
Fig. 3. Concentration–response curves for inhibition of glycerol
 .uptake into cultured hepatocytes condition A by 2,3-dihydroxy-
 .  .propyl-dichloroacetate v , monobutyrin ’ and monoacetin
 .% . Glycerol uptake was determined in the presence of 100 mM
glycerol and increasing concentrations of inhibitors range 0–2
.  .mM . The control value 100% corresponds to an uptake of
1.9"0.4 nmolrmin=mg protein. Results are averages of three
to four individual cell preparations with SEM indicated by verti-
cal bars. IC indicated by dashed line.50
rather than glycerol uptake is the rate limiting step in
liver glycerol metabolism, the kinetic parameters Km
and V for GK were measured using Method IImax
under the same culture conditions as described for
 .glycerol uptake conditions A, B, and C . As can be
seen from Table 1, either the V or the K valuesmax m
were significantly affected by the different culture
 .conditions. In addition, the specific activity V )max
was measured for culture conditions A–F using
 .Method I Table 1 and no differences in GK activi-
ties were observed.
At 100 mM glycerol, the analogues MA and MB
increased the velocity of GK concentration depen-
 .dently Table 2 , suggesting that MA and MB either
act as substrates for GK, or were able to activate the
enzyme by increasing the affinity for glycerol. After
excluding glycerol from the assay mixture, it was still
possible to measure GK activity in the presence of
MA or MB, in a concentration-dependent manner,
although the activity was lower. Since the activity
was measured as a coupled assay with glycerol-3-P
 .dehydrogenase GDH , control experiments revealed
that MA and MB did not influence the activity of
 .GDH results not shown . On the basis of these
observations, it was concluded that MA and MB act
as substrates for GK, and that their phosphorylated
products MA-P and MB-P act as substrates for GDH.
These compounds were further characterized by us-
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Table 2
Glycerol kinase activity in cultured rat hepatocytes in the pres-





Control 6.0"0.2 no activity
q100 mM MA 7.4"0.3) 5.7"0.5
q200 mm MA 8.0"0.3)) 6.9"0.5
q600 mm MA 9.2"0.4))) 8.3"0.6
q100 mM MB 7.1"0.6 5.0"0.2
q200 mM MB 8.0"0.8 6.1"0.7
q600 mM MB 8.9"0.5)) 8.2"0.8
Activity of glycerol kinase in cultured hepatocytes determined by
 .Method I see Section 2 after addition of different concentrations
 .  .of monoacetin MA and monobutyrin MB in the presence and
absence of 100 mM glycerol. Results are average of three
individual cell preparation "SEM. Statistical significant differ-
ences from control are given for data where glycerol was present
 .mid column .
) P -0.05; )) P -0.01; ))) P -0.001.
ing GK from Candida Mycoderma. From Fig. 4 it can
be seen that using either dichloro-MA, MA or MB as
substrates, the GK activity exhibited saturation kinet-
 .Fig. 4. Glycerol kinase from Candida Mycoderma activity using
 .  .  .either glycerol B , monoacetin % , dichloro-monoacetin v
 .or monobutyrin ’ as the substrate. The following kinetic
parameters were calculated. V "SEM nmolrmin=mg pro-max
.  .  .tein : 45.8"1.3 glycerol ; 60.5"0.8))) monoacetin ; 58.0"
 .  .0.7))) dichloro-monoacetin ; 61.5"4.1)) monobutyrin .
 .  . K "SEM mM : 111.4"10.8 glycerol ;169.4"8.0)) mono-m
.  .acetin ; 140.5"6.4) dichloro-monoacetin ; 491.2"72.7)))
 .monobutyrin . Results are averages of four to six individual
experiments with SEM indicated by vertical bars. Statistical
significant differences from glycerol are given ) P -0.05;
.)) P -0.01; ))) P -0.001 .
ics with V values of 58–61 nmolrmin=mg pro-max
tein, which are higher than the V for glycerol 46max
.nmolrmin mg protein . In contrast, the K value form
 .glycerol 111 mM was lower than the K valuesm
obtained with MA, MB and dichloro-MA as sub-
 .strates range 140–491 mM . All substrates resulted
in Hill coefficients of 1.0"0.1.
4. Discussion
The K values found for glycerol uptake are morem
than two fold higher than the range of normal plasma
w xglycerol concentrations of about 60–100 mM 4,5 .
This gives the liver a reserve capacity to take up
transient increases of glycerol and support the notion
that serum levels below 1 mM can be almost com-
w xpletely extracted by the liver 1,2 . The K valuesm
for uptake found in this study are two to four fold
higher than the corresponding values found in
w xNovikoff rat hepatoma cells 10 , and freshly isolated
w xhepatocytes 11 . The obtained K values for GKm
activity were approximately one order of magnitude
lower than those for uptake, whereas V for GKmax
and glycerol uptake were similar. If the efficiency of
glycerol uptake under the different culture conditions
is expressed as the ratio between V and K , amax m
value of 0.03 is obtained. Comparing this value with
 .similar ratios for glycerol kinase 0.20–0.28 , it can
be concluded that the efficiency of glycerol uptake
only constitutes 10–15% of that of GK activity. This
indicates that the rate limiting step for glycerol
metabolism is glycerol uptake which, moreover, is
independent of the culture conditions. However, to
further support this notion in hepatocytes, one would
assume that most of the glycerol taken up, if glycerol
transport is rate limiting, should be metabolized leav-
ing the intracellular glycerol content low. On the
other hand, if glycerol kinase activity is rate limiting,
one should expect a increase in the intracellular
glycerol content. The finding, that glycerol uptake
and the cellular content of phosphorylated metabo-
lites in the presence of DNP were reduced without
altering the cellular content of glycerol, does indeed
substantiate, that glycerol uptake is rate-limiting. This
is in agreement with that previously suggested by Li
w xand Lin 11 using freshly isolated hepatocytes. How-
ever, based only on the obtained kinetic constants one
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would expect, that the cellular content of glycerol in
hepatocytes should be much lower compared to the
cellular content of phosphorylated metabolites, than
that observed in this study. Possible explanations for
 .this could be: 1 The cellular contents of glycerol
and glycerol phosphorylated metabolites were calcu-
lated on the basis of the specific radioactivity of
glycerol in the incubation media at the start of the
incubation period. This may well differ from the
specific radioactivity in the intracellular pool of glyc-
erol from which its metabolites is produced. The
 .content of phosphorylated metabolites and glycerol
therefore represents nominal content which in all
likelihood would be underestimated, if the glycerol
taken up was diluted with the existing cellular pool of
 .glycerol. 2 The K value for G-3-P on GK has beeni
w xreported to be about 0.5 mM 20 , which is in the
same order as the concentration of G-3-P found in the
 . w xliver range 0.2–0.5 mM 2 . Using these values
together with the obtained K values for GK inm
w xTable 1 and assuming competitive inhibition 20,21
the apparent K for glycerol can be calculated to bem
90–100 mM i.e. the glycerol turnover will decrease.
 .3 GK may be found either in the cytosol or bound
to porin on the outer mitochondrial membrane de-
w xpending on the metabolic state 3,22,23 . The appar-
ent K values for ATP and glycerol are lower form
w xthe bound enzyme than for that in the supernatant 3 .
Moreover, beside being a competitive inhibitor of GK
glycerol 3-phosphate also promotes release of porin
w xbound GK in the liver and brain 22,23 . Therefore,
GK kinase activity will also be dependent on the
metabolic status, which under these experimental
conditions is not known.
The present study builds on the assumption, that
glycerol uptake is a non-energy demanding facilitated
process. However, it can not be excluded based on
the present results, that uptake takes place against a
glycerol concentration gradient. Altogether, further
studies are needed to explore this uptake mechanism.
It has been shown that insulin is important for
w xmaintaining GK activity in cultured hepatocytes 24 ,
w xwhile Ref. 25 failed to demonstrate such a depen-
dency. This discrepancy may be explained by differ-
ences in concentrations and exposure times to insulin.
Gluconeogenesis from glycerol may be of major
importance in both cancer and NIDDM due to ele-
vated plasma glycerol levels and glycerol turnover
w x4,5,13,26,27 . Extrapolating the obtained kinetic val-
ues for glycerol uptake to the in vivo situation, and
taking into account that uptake appears to be rate
limiting for glycerol metabolism, an increase in
plasma glycerol from 100 mM to 125 mM, which
corresponds very well with the increased plasma
w xglycerol seen in diabetes 4,5 , will give rise to an
increase in glycerol uptake of about 15–20%. This is
compatible with the elevated glycerol clearance rates
observed in diabetic subjects compared to non-di-
w xabetic subjects 4,5 . In NIDDM subjects there are an
almost two fold increase in gluconeogenesis from
glycerol. Therefore, in addition to increased glycerol
uptake, altered intrahepatic handling of glycerol must
w xtake place as previously suggested 4,5 .
Compounds that inhibit glycerol kinase or in par-
ticular glycerol uptake may be important tools in
attempts to clarify the specific role of glycerol as a
gluconeogenic substrate. All three glycerol analogues
investigated in this study showed inhibition of glyc-
erol uptake. Previously, it was shown that MA com-
petitively inhibited glycerol uptake into freshly iso-
w xlated hepatocytes 11 in the same order as found in
this study. Both MA and dichloro-MA have been
reported as inhibitors of GK with the latter one being
w xnon-competitive in nature 28 . Our data demon-
strated that all three analogues were substrates for
GK originating from hepatocytes and from Candida
Mycoderma, which clearly indicates that the mode of
inhibition was competitive. In this context it should
be mentioned that none of the analogues are sub-
strates for GDH i.e. phosphorylation of the analogues
via GK is a requirement. Again, expressing the effi-
ciency among the different substrates as the V :Kmax m
ratio, the following values were obtained: 0.4
 .  .  .glycerol , 0.4 dichloro-MA , 0.1 MB and 0.4
 .MA , respectively. This indicates that MB was 4
times less efficient as substrate for GK compared to
the other substrates.
Recently, MB, which is synthesized by adipocytes,
has attracted considerably attention because of it’s
w xangiogenic activity 29,30 . It’s biosynthesis appears
w xto be tightly linked to lipolysis 31 and plasma
concentrations in the lower mM range have been
w xfound 30 . However, nothing is known about the
metabolic fate of this compound. On the basis of the
present results, it is suggested that clearance of MB
from plasma might occur via the glycerol transporter
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and subsequently metabolism via GK and GDH.
However, further experiments are needed.
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